Reducing the signs and symptoms of Huntingtons disease by manipulating endocannabinoid tone.
Reducing the signs and symptoms of Huntingtons disease by manipulating endocannabinoid tone.
批准号:
272476
负责人:
Laprairie Robert B
金额:
$0.0万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-10-01 至 2015-10-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The endocannabinoid system is a system of receptors and enzymes that interact with cannabinoids, molecules that are naturally produced by the body and related to the active ingredient in marijuana, THC, to cause context-specific effects. In the brain, the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Type 1 Cannabinoid Receptor Positive Allosteric Modulators for Infantile Spasms
-
批准号:410481
-
项目类别:Operating Grants
-
资助金额:$50.44万
-
财政年份:2019
-
负责人:Laprairie Robert B
-
依托单位:
Novel Type 1 Cannabinoid Receptor Allosteric Modulators
-
批准号:367883
-
项目类别:Operating Grants
-
资助金额:$13.66万
-
财政年份:2017
-
负责人:Laprairie Robert B
-
依托单位:
Characterization of ligand bias at the type 1 cannabinoid receptor
-
批准号:338100
-
项目类别:Fellowship Programs
-
资助金额:$7.29万
-
财政年份:2015
-
负责人:Laprairie Robert B
-
依托单位:
Regulation of type 1 cannabinoid receptor expression in Huntington's disease.
-
批准号:224312
-
项目类别:Studentship Programs
-
资助金额:$1.27万
-
财政年份:2011
-
负责人:Laprairie Robert B
-
依托单位:
海外基金